Marina Sibila i Vidal

Centre de Recerca en Sanitat Animal (CReSA) - Spain Author

Marina Sibila i Vidal was born in Navàs (Barcelona) in 1975. In 1999, she obtained the bachelor’s in Science at the Biological Science Faculty of the Barcelona University (UB). In 2004, she obtained the PhD for the work entitled “Epidemiological features of Mycoplasma hyopneumoniae (M. hyopneumoniae) natural infection in pigs in Spain” at the Veterinary Faculty of the Universitat Autònoma de Barcelona (UAB). Since then, she is working at Centre de Recerca en Sanitat Animal (CReSA) from the Agrifood Research and Technology Institute (IRTA) as a researcher. Her research line is centered on different aspects of infection, including pathogenesis, molecular epidemiology, establishment of animal models, diagnostic tool development and control strategies assessment mainly on Mycoplasma (M) hyopneumoniae, M. hyorhinis, porcine circovirus 2 (PCV-2) and PCV-3 associated diseases. In the last years, she has expanded her research to study the role of the nasal microbiota on the diseases caused by pathogens that enters through the respiratory tract. As a result of these investigations, she is the author or co-author of more than 95 scientific papers published in international scientific journals and co-author of different book chapters and co-editor of a book entitled Mycoplasmas in Swine.  Dr Sibila also participates in the “Master universitario en sanidad y producción porcina” given by Universidad de Lleida, Complutense de Madrid and de Zaragoza and as a co-advisor of several PhD thesis focused mainly on PCV-2, PCV-3, M. hyopneumoniae and on the role of the nasal microbiota on polyserositis problems.

Updated CV 19-May-2023

TwitterLinkedinTelegramTelegram
3 Likecomment
share
My favorites
TwitterLinkedinTelegramTelegram
4 Likecomment
share
My favorites
TwitterLinkedinTelegramTelegram
6 Likecomment
share
My favorites
TwitterLinkedinTelegramTelegram
10 Likecomment
share
My favorites
TwitterLinkedinTelegramTelegram
10 Like3 Comments
share
My favorites
07-Mar-2018Marius Opreain my opinion, sow blanket vaccination against PCV2 will have a big impact in pigs vaccination against PCV2. Some farmers are happy that are vaccinating all the sows at once, but they forget about piglets that are born from those sows. Depending on status of sows at vaccination time (lactation or various age of gestation) piglets will have different levels of MDA and it is mandatory to make ELISA checking before vaccination
TwitterLinkedinTelegramTelegram
6 Like1 Comments
share
My favorites
24-Mar-2017chtouchweak 2 or 3 or..... for vaccination? not clear identification
TwitterLinkedinTelegramTelegram
Like4 Comments
share
My favorites
16-Sep-2014msibilaKim et al., 2011. Comparative efficacy of commercial Mycoplasma hyopneumoniae and porcine circovirus 2 (PCV2) vaccines in pigs experimentally infected with M. hyopneumoniae and PCV2
Vaccine (29). 3206–3212.

Welcome to 333

Connect, share, and interact with the largest community of professionals in the swine industry.

Celebrating 151750Users on 333!

Sign upAlready a member?
Recommended accounts
DAVI  LIOU

DAVI LIOU

Other - China
Zhou  Lydia

Zhou Lydia

Other - China
ECO Animal Health
Company - United Kingdom
Idexx

Idexx

Company - Netherlands
Tonisity

Tonisity

Company - Ireland